Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK2 | P24941 | 10/20 | 0.79 |
| ▸ | GSK3B | P49841 | 10/20 | 0.79 |
| ▸ | CCNE1 | P24864 | 5/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13304678 | 0.92 | GSK3B (0.67) | CDK2GSK3BCCNE1 | |
| SCHEMBL13288631 | 0.90 | GSK3B (0.65) | CDK2GSK3BCCNE1CYP1A2CYP3A4 | |
| SCHEMBL12952876 | 0.88 | GSK3B (1.00) | CDK2GSK3BCCNE1 | |
| SCHEMBL13305311 | 0.88 | GSK3B (0.79) | CDK2GSK3BCCNE1CYP1A2CYP3A4 | |
| SCHEMBL13146486 | 0.88 | CDK2 (0.79) | CDK2GSK3BCCNE1 | |
| SCHEMBL13289612 | 0.87 | CDK2 (0.60) | CDK2GSK3BCCNE1 | |
| SCHEMBL13146048 | 0.85 | GSK3B (0.77) | CDK2GSK3BCCNE1 | |
| SCHEMBL13305391 | 0.85 | CDK2 (0.58) | CDK2GSK3BCCNE1 | |
| SCHEMBL13305313 | 0.85 | CDK2 (0.64) | CDK2GSK3BCCNE1 | |
| SCHEMBL13305196 | 0.85 | CDK2 (0.63) | CDK2GSK3BCCNE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1537116-B1 | PYRAZOLOPYRIMIDINES SUITABLE FOR THE TREATMENT OF CANCER DISEASES | SCHERING CORP (US) | 2010-06-02 | — | — | EP | disclosed |